
Vivodyne is a biotechnology company revolutionizing therapeutics development by providing preclinical human data before clinical trials. Their platform integrates three key breakthroughs: complex human tissue engineering using lab-grown organ models, highly scalable robotics for massive automated studies testing thousands of human tissues simultaneously, and cutting-edge AI for data analysis and experimental design. This enables them to generate predictive human data at AI-scale, accelerating the discovery of new targets and therapies. Vivodyne partners with leading biopharma companies, claiming to have collaborated with over half of the top-10 pharmaceutical companies worldwide, to bring safer and more effective treatments to patients, aiming to replace animal testing with a more sustainable, human-relevant solution.

Vivodyne is a biotechnology company revolutionizing therapeutics development by providing preclinical human data before clinical trials. Their platform integrates three key breakthroughs: complex human tissue engineering using lab-grown organ models, highly scalable robotics for massive automated studies testing thousands of human tissues simultaneously, and cutting-edge AI for data analysis and experimental design. This enables them to generate predictive human data at AI-scale, accelerating the discovery of new targets and therapies. Vivodyne partners with leading biopharma companies, claiming to have collaborated with over half of the top-10 pharmaceutical companies worldwide, to bring safer and more effective treatments to patients, aiming to replace animal testing with a more sustainable, human-relevant solution.
Vivodyne creates human data before clinical trials. We accelerate the successful discovery, design, and development of human therapeutics by testing on large, lab-grown human organ tissues at massive scale, driving technological advancement at the convergence of novel biology, robotics, and AI. We identify and validate new therapeutic targets and de-risk new therapeutic assets by producing clinically translatable multi-omic data from our proprietary, physiologically-realistic human organ tissues at unprecedented scale, speed, and quality. This enables us to produce more human data than all clinical trials in the U.S. combined. We’re financially backed by some of the most selective and successful venture funds, and we have already partnered with a majority of the top 10 multinational pharmaceutical companies to discover and develop better, safer drugs and dramatically reduce the burden of animal testing.
www.vivodyne.com
The Director, Business Development is a senior individual contributor responsible for sourcing, advancing, and closing strategic partnerships with mid-sized and large pharmaceutical companies. This role carries a significant individual bookings target and is accountable for building and converting a high-quality pipeline aligned with Vivodyne’s commercial priorities.
The Director, Business Development will operate with a high degree of autonomy and strategic judgment; owning account strategy, shaping deal structures, and leading cross-functional execution across Science, Bio, Legal, and Finance. Success in this role requires balancing hands-on deal execution with thoughtful account planning and market insight.
Responsibilities Ownership & Deal Execution
Run weekly pipeline reviews to reduce slippage, re-qualify deals, and improve forecast accuracy.
Account Strategy & Pipeline Management
Strategic Contribution
Cross-Functional Deal Leadership
Event Engagement
Requirements Required
Preferred
San Francisco pay range{{:}} $170,000 USD - $275,000 USD